bpc-157 clinical trials 2025 This is the first vote from the FDA's Pharmacy Compounding Advisory Committee on one of 7 peptides up for consideration. While the committee advises through these votes, ultimately the FDA will make BPC-157: Miracle Healing Peptide or

10.3389/fphar.2021.693983 59 ZhouX.WangG.WangX.LiuL.ZhangQ.YinY.et al (2017)

BPC-157 has been shown to upregulate epidermal growth factor (EGF), vascular endothelial growth factor (VEGF), fibroblast growth factor-2 (FGF-2), and nerve growth factor (NGF) expression in multiple rodent tissue models

Experimental models indicate that the peptide may contribute to the restoration of tendons and ligaments by improving local vascular responses at injury sites

Embo Journal 13 , 44594468 (1994)

One review found that while human growth hormone increases muscle mass, it may not improve strength, it can worsen exercise capacity and increase your risk of experiencing swelling, fatigue, carpal tunnel syndrome, joint pain and sweating